Printer-friendly version
AlloSkin™ RT human meshed dermal allograft is extensively tested, cleaned, and sterilized for room temperature storage. Contains extracellular matrix proteins, glycosaminoglycans, cytokines, and other natural vulnerary compounds that may interact to promote wound healing.
• Room temperature graft eliminates clinical time to thaw and the need for costly cryo freezer
• Pliable, stretchable tissue allows graft contouring to wound topography
• Robust enough to suture or staple without tearing
• Meshing encourages fluid draining from wound
AlloSkin™ RT can be used in a homologous fashion on any skin defect and is appropriate for use in traumatic and chronic wounds, including those where substructures such as bone, ligament, nerve, or muscle are exposed.
Contraindicated for use when gross infection at the transplantation site is present.
As with all biological products, the tissue from AlloSkin™ RT has the potential to transmit infectious agents despite processing treatments, extensive donor screening, tissue selection, and laboratory tests. See package insert for full listing.
Inherent uncertainty exists in medical and social histories and laboratory testing which may not detect known or unknown pathogens. Therefore, the following complications may occur with tissue transplantation: loss of integrity of transplanted tissue, immune response to transplanted tissue, transmission of known pathogens, and transmission or causation of disease of unknown etiology and characteristics. Adverse outcomes potentially attributable to AlloSkin™ RT must be promptly reported to the manufacturer. See package insert for full listing.
Room temperature storage. Shelf life of 2 years.
| Assigned HCPCS code | ● |
| Cryopreserved | |
| Dehydrated | |
| Desiccated | |
| Flowable | |
| Micronized | |
| Minimally manipulated | |
| Sheet form | |
| Requires refrigeration | |
| Shelf life greater than 2 years | |
| Shelf life limited | ● |
| Indicated for acute wounds | ● |
| Indicated for chronic wounds | ● |
| Indicated for diabetic ulcers | ● |
| Indicated for pressure ulcers | ● |
| Indicated for surgical wounds | ● |
| Indicated for third-degree burns | ● |
| Indicated for venous ulcers | ● |
| Contact manufacturer for usage guidelines |
| Educational Material Available | ● |
| Free Samples/Trials Available | ● |
| Published Clinical Article Available |
Acute Wounds
Burns
Chronic Wounds
Dehisced Wounds
Diabetic Foot
Granulating/Epithelializing Wounds
Non/Minimally Exudating Wounds
Pressure Ulcers
Surgical Wounds
Venous Ulcers
Ensure wound is adequately debrided and free of infection. Rinse in saline or sterile isotonic solution prior to applying to wound. Affix AlloSkin™ RT per physician preference: can be stapled, sutured, glued, or tacked.
Inspect wound weekly, sooner if deemed necessary, to determine if AlloSkin™ RT is still in place or beginning to slough. Tissue generally sloughs in 7-14 days as wound bed granulation proceeds. Depending on wound assessment, clinician may leave graft in place. Additional applications are used if satisfactory closure has not been achieved with initial application. Typical wounds close with 1 to 3 applications.
Apply any combination of non-adherent sterile dressing over AlloSkin™ RT.
Non-cytotoxic
Sterile
AlloSource is a non-profit organization that offers more than 200 types of precise skin, bone, soft-tissue, and other allografts for use in an array of life-saving and life-enhancing medical procedures.